Oxford BioMedica PLC
SWB:OXOA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oxford BioMedica PLC
SWB:OXOA
|
UK |
|
K
|
Koses Co Ltd
KOSDAQ:089890
|
KR |
|
N
|
Norvista Capital Corp
XTSX:OC
|
CA |
|
M
|
Mittel SpA
MIL:MIT
|
IT |
|
S
|
Strike Energy Ltd
XMUN:RJN
|
AU |
|
Elutia Inc
NASDAQ:ELUT
|
US |
|
Evergreen Gaming Corp
XTSX:TNA
|
US |
|
Lum Chang Creations Ltd
SGX:LCC
|
SG |
|
Zhejiang Xinhua Chemical Co Ltd
SSE:603867
|
CN |
|
SolarWorld AG
OTC:SRWRF
|
DE |
|
S
|
Sam Holdings Corp
VN:SAM
|
VN |
|
O
|
OPG Power Ventures PLC
SWB:OPB
|
IM |
|
O
|
OPG Power Ventures PLC
XBER:OPB
|
IM |
|
OPG Power Ventures PLC
F:OPB
|
IM |
Wall St Price Targets
OXOA Price Targets Summary
Oxford BioMedica PLC
According to Wall Street analysts, the average 1-year price target for OXOA is 8.54 EUR with a low forecast of 5.84 EUR and a high forecast of 10.76 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OXOA's stock price target?
Price Target
8.54
EUR
According to Wall Street analysts, the average 1-year price target for OXOA is 8.54 EUR with a low forecast of 5.84 EUR and a high forecast of 10.76 EUR.
What is the Revenue forecast for Oxford BioMedica PLC?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 18%.
What is the Gross Profit forecast for Oxford BioMedica PLC?
Projected CAGR
23%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 23%.
